Part 1: Barriers to Optimizing the Use of Insulin in Managing Type 2 Diabetes

In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding the barriers to optimizing the use of insulin in managing patients with type 2 diabetes. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc.

Faculty:

Curtis Triplitt, PharmD, CDE

Associate Director, Diabetes Research Center, Texas Diabetes Institute

Associate Professor, Department of Medicine, Division of Diabetes

University of Texas Health Science Center at San Antonio

San Antonio, Texas

Susan Cornell, PharmD, CDE, FAPhA, FAADE

Associate Director of Experiential Education

Associate Professor, Department of Pharmacy Practice

Midwestern University Chicago College of Pharmacy

Downers Grove, Illinois

Joshua Neumiller, PharmD, CDE, FASCP

Vice Chair and Associate Professor, Department of Pharmacotherapy

Washington State University College of Pharmacy

Spokane, Washington

C.E. Credits: This activity is not eligible for continuing education credits.